Find out more about our subscription products and services by visiting our websites: CorporateHealthcareEnergy
Report Store

Search Within Market Intelligence

Keywords:
Search In
Industry:
Pub Month: From  To 
Price Range ($): Min       Max
 
 
 
 
Free Research Alert
Sign up for updates on the latest research
Email: 
 
 
Call us now on +44 1204 543 529
to speak to an advisor
 

Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends

Published: Nov-2012    Report Format:
Report Code: GDHC001MAL
Pharmaceuticals and Healthcare
Single User License
Single User License
$2995
Site License
Site License
$5990
Global License
Global License
$8985
GlobalData’s Biotech Strategy 2012: Licensing, Collaboration, and M&A Trends report analyzes 20 strategic deals struck by leading and promising biotech companies. The terms and strategic drivers of these deals are analyzed based on acquisition costs, strategic fit, potential revenues, competitive advantage as well as other measures to illustrate the strategies different companies are currently using to gain market share, increase shareholder value and bring innovative and life-saving products to the booming global pharmaceuticals market. This report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market.

Scope

  • The report provides full details of 20 significant deals from Q3 2011 to Q3 2012 involving promising biotech companies including deal terms and payment structure.
  • The report provides analysis of the key drivers, trends, and strategies behind deals undertaken by biotech companies across important geographic regions including the US, EU, Asia-Pacific, Brazil, Russia, India, China, and other emerging markets.
  • The report covers the six major therapy areas of cardiovascular disease, central nervous system (CNS), diabetes and metabolic, immunology, oncology, and respiratory.
  • The report contains expert insights on the corporate strategies of emerging biotech companies seeking competitive advantage in the pharmaceuticals marketplace.


About The Report

The Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends report is an essential source of information and analysis on global strategic deals involving the top players in the global pharmaceuticals market. Using detailed company data and financial analysis, GlobalData has highlighted certain deals in the pharmaceuticals market, forming a basis for in-depth analysis of the factors driving deal-making in the industry, currently and into the future. The report discusses the key factors shaping and driving the global pharmaceutical industry, and provides insight on the competitive landscape and emerging strategies that are expected to significantly alter the market position of industry leaders.

Request Sample Pages

First Name*:
Last Name*:
Company / Organization*:
Email Address*:
Country*:
Phone Number*:  
Time Zone:
Comments:
 
© GlobalData 2014. John Carpenter House, 7 Carmelite Street, London EC4 O85.